Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase NA 8Phase 3 8Phase 2/3 2Phase 1 2Phase 4 1

Status

Completed 135Terminated 21Withdrawn 9Unknown 7Active not recruiting 7Recruiting 3Not yet recruiting 2Suspended 1

Sponsor Class

OTHER 216INDUSTRY 212OTHER_GOV 10NIH 7NETWORK 2FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Triple Negative Breast Neoplasms 1Sarcoma, Alveolar Soft Part 1GastroEsophageal Cancer 1Carcinoma, Renal Cell 1

Interventions

fludarabine 1bemarituzumab 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Not yet recruiting × NETWORK × Clear all
NCT07297667 2026-05-12

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

Canadian Cancer Trials Group

Phase 1 Not yet recruiting
30 enrolled
BreastGenitourinarySarcoma

Carcinoma, Renal Cell, Sarcoma, Alveolar Soft Part, Triple Negative Breast Neoplasms

NCT06978062 2025-06-05

NeoBEMA

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1 Not yet recruiting
27 enrolled
Gastrointestinal

GastroEsophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡